Additionally, a study by Järventausta and colleagues found that IL-6 levels decreased towards the end of ECT treatment, which correlated with patient response scores, as measured by the Montgomery–Åsberg Depression Rating Scale (MADRS) [59]. This evidence concerns the gene IL6 and major depressive disorder.